Cellular uptake of adamantyl conjugated peptide nucleic acids

Bioconjugate Chemistry

Volumn 10, Issue 6, 1999, Pages 965-972

  Ljungstrøm, Trine ^a   Knudsen, Helle ^a   Nielsen, Peter E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; DYES; FLUORESCENCE MICROSCOPY; NUCLEIC ACIDS; PEPTIDES;

ACID MODIFICATION; CATIONIC LIPOSOMES; CELL LINES; CELL TYPES; CELLULAR UPTAKE; CONFOCAL FLUORESCENCE MICROSCOPY; HUMAN CELLS; INTRACELLULAR LOCALIZATION; PEPTIDE NUCLEIC ACID; SIMPLE++;

LIPOSOMES;

EID: 0033231323     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990053+     Document Type: Article

References (53)

1. Agrawal, S. (1996) Antisense oligonucleotides: towards clinical trials. Trends Biotechnol. 14, 376-387.
2. Agrawal, S., and Iyer, R. P. (1995) Modified oligonucleotides as therapeutic and diagnostic agents. Curr. Biol. 6, 12-19.
3. Aldrian-Herrada, G., Desarménien, M. G., Orcel, H., Boissin-Agasse, L., Méry, J., Brugidou, J., and Rabie, A. (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. 26 (21), 4910-4916.
4. Altmann, K. H., Dean, N. M., Fabbro, D., Freier, S. M., Geiger, T., Häner, R., Hüsken, D., Martin, P., Monia, B. P., Müller, M., Natt, F., Nicklin, P., Phillips, J., Piels, U., Sasmor, H., and Moser, H. E. (1996) Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals. Chimia 50, 168-176.
5. Basu, S., and Wickstrom, E. (1997) Synthesis and Characterization of a Peptide Nucleic Acid Conjugated to a D-Peptide Analogue of Insulin-like Growth Factor 1 for Increased Cellular Uptake. Bioconjugate Chem. 8, 481-488.
6. Bennet, C. F. (1998) Antisense Oligonucleotides: Is the Glass Half Full or Half Empty? Biochem. Pharrnacol. 55, 9-19.
7. Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E. E., and Mirabelli, C. K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023-1033.
8. Bonham, M. A., Brown, S., Boyd, A. L., Brown, P. H., Bruckenstein, D. A., Hanvey, J. C., Thomson, S. A., Pipe, A., Hassman, F., Bisi, J. E., Froehler, B. C., Matteucci, M. D., Wagner, R. W., Noble, S. A., and Babiss, L. E. (1995) An assassment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res. 23, 1197-1203.
9. Boutorine, A. S., and Kostina, E. V. (1993) Reversible covalent attachment of cholesterol to oligodeoxyribonucleotides for studies of the mechanisms of their penetration into eukaryotic cells. Biochimie 75, 35-41.
10. Brown, S. C., Thomson, S. A., Veal, J. M., and Davis, D. G. (1994) NMR solution structure of a peptide nucleic acid complexed with RNA. Science 265, 777-780.
11. Campbell, M. J. (1995) Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 18, 1027-1032.
12. Cherny, D. Y., Belotserkovskii, B. P., Frank-Kamenetskii, M. D., Egholm, M., Buchardt, O., Berg, R., and Nielsen, P. E. (1993) DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double-stranded DNA. Proc. Natl. Acad. Sci. U.S.A. 90, 1667-1670.
13. Christensen, L., Fitzpatrick, R., Gildea, B., Petersen, K. H., Hansen, H. F., Koch, T., Egholm, M., Buchardt, O., Nielsen, P. E., Coull, J., and Berg, R. H. (1995) Solid-phase synthesis of peptide nucleic acids (PNA) J. Pept. Sci. 3, 175-183.
14. De Mesmaeker, A., Altmann, K. H., Waldner, A., and Wendeborn, S. (1995) Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr. Opin. Struct. Biol. 5, 343-355.
15. Demidov, V., Potaman, V. N., Franck-Kamenetskii, M. D., Egholm, M., Buchardt, O., Sönnichsen, S. H., and Nielsen, P. E. (1994) Stability of peptide nucleic acids in serum and cellular extracts. Biochem. Pharmacol. 48, 1309-1313.
16. Egholm, M., Nielsen, P. E., Buchardt, O., and Berg, R. H. (1992a) Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA). J. Am. Chem. Soc. 114, 9677-9678.
17. Egholm, M., Buchardt, O., Nielsen, P. E., and Berg, R. H. (1992b) Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J. Am. Chem. Soc. 114, 1895-1897.
18. Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365, 566-568.
19. Eriksson, M., and Nielsen, P. E. (1996a) Solution Structure of a Peptide Nucleic Acid-DNA Duplex. Nat. Struct. Biol. 3, 410-413.
20. Eriksson, M., and Nielsen, P. E. (1996b) PNA-nucleic acid complexes. Structure, stability and dynamics Q. Rev. Biocphys. 29, 369-394.
21. Freier, S. M., and Altmann, K. H. (1997) The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically modified DNA: RNA duplexes. Nucleic Acids Res. 25, 4429-4443,
22. Gambacorti-Passerini, C., Mologni, L., Bertazzoli, C., Marchesi, E., Grignani, F., and Nielsen, P. E. (1996) In vitro transcription and translation inhibition by anti-Promyelocytic Leukemia (PML)/Retinoic acid receptor a and anti-PML peptide nucleic acid. Blood 88, 1411-1417.
23. Good, L., and Nielsen, P. E. (1997) Progress in developing PNA as gene targeted drugs. Antisense Nucleic Acid Drug Dev. 7, 431-437.
24. Gray, G. D., Basu, S., and Wickstrom, E. (1997) Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3′-alkylamino oligonucleotides, 2′-O-methyl oligonucleotides, oligodeoxynucleoside methylphosphonates and peptide nucleic acids. Biochem. Pharmacol. 53, 1465-1476.
25. Haaima, G., Lohse, A., Buchardt, O., and Nielsen, P. E. (1996) Peptide Nucleic Acids (PNA) containing thymine monomers derived from chiral amino acids.: Hybridization and solubility properties of d-lysine PNA. Angew. Chem. 35, 1939-1941.
26. Hamilton, S. E., Simmons, C. G:, Kathiriya, I. S., and Corey, D. R. (1999) Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6, 343-351.
27. Hanvey, J. C., Peffer, N. J., Bisi, J. E. Thomson, S. A., Cadilla, R., Josey, J. A., Ricca, D. J., Hassman, C. F., Bonham, M. A., Au, K. G., Carter, S. G., Bruckenstein, D. A., Boyd, A. L., Noble, S. A., and Babiss, L. E. (1992) Antisense and antigene properties of peptide nucleic acids. Science 258, 1481-1485.
28. Hubus, I., Zhao, Q., and Agrawal, S. (1995) Synthesis, Hybdridization properties, nuclease stability, and cellular uptake of oligonucleotide-amino-b-cyclodextrins and adamantane conjugates. Bioconjugate Chem. 6, 327-331.
29. Hyrup, B., and Nielsen, P. E. (1996) Peptide Nucleic Acids (PNA). Synthesis, Properties and Potential Applications (review). Bioorg. Biomed. Chem. 4, 5-23.
30. Jensen, K. K., Ørum, H., Nielsen, P. E., and Norden, B. (1997) Hybridization Kinetics of Peptide Nucleic Acids (PNA) with DNA and RNA Studied with BIAcore Technique. Biochemistry 36, 5072-5077.
31. Kabanov, A. V., Vinogradov, S. V., Ovcharenco, A. V., Krivonos, A, V, Melik-Nubarov, N. S., Vsevolod, I., and Severin, E. S. (1990) A new cass of antivirals: antisense oligonucleotides combined with a hydrophobic substituent efficiently inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells. FEBS Lett. 259, 327-330.
32. Kim, S. K., Nielsen, P. E., Egholm, M., Buchardt, O., Berg, R. H., and Norden, B. (1993) Right-handed triplex formed between peptide nucleic acid PNA-T8 and poly(dA) shown by linear and circular dichroism spectroscopy. J. Am. Chem. Soc. 115, 6477-6481.
33. Knudsen, H., and Nielsen, P. E. (1996) Antisense properties of duplex-and triplex-forming PNAs. Nucleic Acids Res. 24, 494-500.
34. Leijon, M., Graslund, A., Nielsen, P. E., Buchardt, O., Norden, B., Kristensen, S. M., and Eriksson, M. (1994) Structural characterization of PNA-DNA duplexes by NMR. Evidence for DNA in a B-like conformation. Biochemistry 33, 9820-9825.
35. Letsinger, R. L., Zhang, G. R., Sun, D. K., Ikeuchi, T., and Sarin, P. S. (1989) Cholesteryl-conjugated oligonucleotides: synthesis, properties and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc. Natl. Acad. Sci. U.S.A. 86, 6553-6556.
36. Lohse, J., Nielsen, P. E., Harrit, N., and Dahl, O. (1997) Fluorescein-conjugated lysine monomers for solid-phase synthesis of fluorescent peptides and PNA oligomers. Bioconjugate Chem. 8, 503-509.
37. Mishra, R. K., Moreau, C., Ramazeilles, C., Moreau, S., Bonnet, J., and Toulme, J. J. (1995) Improved leishmanical effect of phosphorothioate antisense oligonucleotides by LDL-mediated delivery. Biochim. Biophys. Acta 1264, 229-237.
38. Mologni, L., LeCoutre, P., Nielsen, P. E., and Gambacorti-Passerini, C. (1998) Additive antisense effects of different PNAs on the in vitro translation of the PML/RAR α-gene. Nucleic Acids Res. 26, 1934-1938.
39. Nielsen, P. E., Egholm, M., Berg, R. H., and Buchardt, O. (1991) Sequence-selective recognition of PNA by strand displacement with a thymine-substituted polyamide. Science 254, 1497-1500.
40. 2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement. J. Mol. Recognit. 7, 165-170.
41. Nielsen, P. E., Egholm, M., and Buchardt, O. (1994b) Sequence-specific transcription arrest by nucleic acid bound to the DNA template strand. Gene 149, 139-145.
42. Pooga, H., Soomets, U., Hällbrink, M., Valkna, A, Saar, K, Rezaei, K., Kahl, U, Hao, J.-X, Xu, X.-J., Wiesenfeld-Hallin, Z., Hökfelt, T., Bartfai, T., and Langel, Ü. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
43. Saison-Behmoaras, T., Tocqué, B., Rey, I., Chassignol, M., Thuong, N. T., and Hélène, C. (1991) Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation. EMBO J. 10, 1111-1118.
44. Sharma, H. W., and Narayanan, R. (1995) The therapeutic potential of antisense oligonucleotides. BioAssays 17, 1055-1063.
45. Simmons, C. G., Pitts, A. E., Mayfield, L. D., Shay, J. W., and Corey, D. R. (1997) Synthesis and Membrane Permeability of PNA-Peptide Conjugates. Bioorg. Med. Chem. Lett. 7 (23), 3001-3006.
46. Stein, C. A., Pal, R., DeVico, A. L., Hoke, G., Mumbauer, S., Kinstler, O., Sarngadharan, M. G., and Letsinger, R. L. (1991) Mode of action of 5′-linked cholesteryl phosphorothio-ate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry 30, 2439-2444.
47. Svinarchuk, F. P., Konevetz, D. A., Pliasunova, O. A., Pokrovsky, A. G., and Vlassov, V. V. (1993) Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie 75, 49-54.
48. Taylor, R. W., Chinnery, P. F., Turnbull, D. M., and Lightowlers, R. N. (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat. Genet. 15, 212-215.
49. Thierry, A. R., and Dritschillo, A. (1992) Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res. 20, 5691-5698.
50. Uhlmann, E., Will, D. W., Breipohl, G., Langner, D., and Ryte, A. (1996) Synthesis and properties of PNA/DNA chimeras. Angew. Chem., Int. Ed. Engl. 35, 2632-2633.
51. Wagner, R. W., and Flanagan, M. (1997) Antisense technology and prospects for therapy of viral infections and cancer. Mol. Med. Today 1, 31-38.
52. Wielbo, D., Shi, N., and Serina, C. (1997) Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery. Biochem. Biophys. Res. Commun. 232, 794-799.
53. Zelpathy, O., and Szoka, F. C., Jr. (1996) Intracellular distribution and mechanism of delivery of oligonucleotides by cationic lipids. Pharm. Res. 13, 1367-1372.